Asperger syndrome future or investigational therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
There have been some experimental therapy and suggestions such as oxytocin and treatment with stem cells in patients with Asperger Syndrome (AS).[1]
Future or Investigational Therapies
Experimental therapy for Asperger Syndrome (AS) include:[1]
Oxytocin
- Contributions to repetitive behaviors and social deficiencies in Asperger Syndrome (AS) by oxytocin have suggested oxytocin as an experimental therapy in autism spectrum disorder (ASD) and Asperger Syndrome (AS).[2]
- In patients with AS and ASD, the preliminary manipulation of systemic oxytocin levels have suggested a positive correlation in social awareness, social recognition and peer affiliation.[3]
Stem cells
- Treatment of AS and ASD with stem cells is in the early stages.[1]
References
- ↑ 1.0 1.1 1.2 Tarazi FI, Sahli ZT, Pleskow J, Mousa SA (2015). “Asperger’s syndrome: diagnosis, comorbidity and therapy”. Expert Rev Neurother. 15 (3): 281–93. doi:10.1586/14737175.2015.1009898. PMID 25655905.
- ↑ Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR; et al. (2003). “Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders”. Neuropsychopharmacology. 28 (1): 193–8. doi:10.1038/sj.npp.1300021. PMID 12496956.
- ↑ Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010). “Promoting social behavior with oxytocin in high-functioning autism spectrum disorders”. Proc Natl Acad Sci U S A. 107 (9): 4389–94. doi:10.1073/pnas.0910249107. PMC 2840168. PMID 20160081.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH